American Bio Medica Corp (fka ABMC)

[Ronin]

Insider Selling ends on Sept. 24th, as per 10-K/A from July 2020...


"60 days of selling" is almost over..."

Melissa has answered my other emails. She did not answer this one yet from yesterday...


Dear Ms. Watherhouse,

Are you able to verify if the people mentioned below in the July 2020 10-K/A (https://www.otcmarkets.com/filing/html?id=14287313&guid=0Rt6UHOfTrILi3h) need to submit an SEC FORM 4 if they are selling ABMC shares?

Thank you for letting me know...

Common
Chaim Davis
3,309,047(1)
9.18%
Common
Melissa A. Waterhouse
1,250,000(2)
3.36%
Common
Jean Neff
186,226(3)
*
Common
Peter Jerome
120,610(4)
*
Common
Directors and Executive Officers as a group (5 persons)
4,865,883(5)
12.99%
Common
MP Biomedicals LLC
4,738,601(6)
13.18%
Common
John J. Moroney
2,481,608(7)
6.90%
Common
Stuart Sternberg
2,428,671(8)
6.76%

(1) Includes 215,838 shares issued to Chaim Davis in connection with his attendance at meetings of our Board of Directors in the years ended December 31, 2018 and December 31, 2019 and meetings of our Board of Directors (as of the date of this report) held in the year ending December 31, 2020, as well as 2,978,486 shares in the name of Revach Fund, LP. (Chaim Davis is a managing member of Revach Group, LLC which operates as the general partner of the Revach Fund, LP). Also includes 24,723 shares held by Mr. Davis directly prior to his appointment to our Board of Directors and 90,000 common shares subject to stock options exercisable within 60 days of July 24, 2020.

(2) Includes 1,250,000 common shares subject to stock options exercisable within 60 days of July 24, 2020.

(3) Includes 66,226 shares issued to Jean Neff in connection with her attendance at meetings of our Board of Directors in the year ended December 31, 2019 and meetings of our Board of Directors (as of the date of this report) held in the year ending December 31, 2020, as well as 120,000 common shares subject to stock options exercisable within 60 days of July 24, 2020.

(4) Includes 80,610 shares issued to Peter Jerome in connection with his attendance at meetings of our Board of Directors in the year ended December 31, 2019 and meetings of our Board of Directors (as of the date of this report) held in the year ending December 31, 2020, as well as 40,000 common shares subject to stock options exercisable within 60 days of July 24, 2020.

(5) Includes an aggregate of 1,500,000 common shares subject to stock options exercisable within 60 days of July 24, 2020.

(6) Information based on the last Section 16(a) filing made by MP Biomedicals LLC on December 22, 2015. The last known address for MP Biomedical LLC is 3 Hutton Centre Drive, Suite 100, Santa Ana, California 92707.

(7) Information based on last Schedule 13G/A filed by John J. Moroney, a principal of Landmark Pegasus, Inc. on April 27, 2020. The address for Mr. Moroney (indicated on the Schedule 13G/A) is 118 Pegasus Drive, Jupiter, FL 33477.

(8) Information based on the last Schedule 16G filed by Stuart Sternberg on June 24, 2020. The address for Mr. Sternberg (indicated on the Schedule 13G) is 85 Bellevue Avenue, Rye NY 10580.

Note: Diane Generous resigned from the Board of Directors on January 10, 2020. Given this, the Company cannot confirm the beneficial ownership of Ms. Generous as of the date of this report.

https://www.otcmarkets.com/filing/html?id=14287313&guid=0Rt6UHOfTrILi3h